MAY 19, 2013 | LAST UPDATED MAY 19, 2013 4:46 PM
By Emily Micucci
Five years after Bristol-Myers Squibb finished building its first Massachusetts manufacturing facility in Devens, the region continues to reap the benefits of the biopharmaceutical company’s decision to locate here.
That’s because Bristol-Myers Squibb (NYSE: BMY) is expanding its operations in Devens, bringing new jobs and tax revenue, and adding to the ever-expanding life sciences footprint in Massachusetts. The $250 million project, slated to begin at the end of 2013, will add two buildings to the existing Bristol-Myers’ Devens campus, which now includes four structures on an 89-acre campus tucked away off Jackson Road. The facility has focused mainly on large-scale bulk biologics manufacturing. At roughly 200,000 square feet, the new construction will add capabilities, including early production of investigational biologics medicines and manufacturing to support clinical drug trials.